Seragen, Sandoz Pharma Ltd. deal

Sandoz will license certain SRGN patents relating to transplantation. Included in the license is U.S. Patent No. 5,011,684, which covers the use of interleukin-2 (IL-2) receptor targeted monoclonal a...